Cargando…

Proton Therapy for Malignant Pleural Mesothelioma: A Three Case Series Describing the Clinical and Dosimetric Advantages of Proton-Based Therapy

Malignant pleural mesothelioma (MPM) is a malignancy of the pleural cavity that typically presents at an advanced stage. Due to its large, circumferential clinical target volume (CTV) and proximity to major structures, including the heart and contralateral lung, delivering hemithoracic intensity-mod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Howard, Zeng, Jing, Bowen, Stephen R, Rengan, Ramesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2017
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690429/ https://www.ncbi.nlm.nih.gov/pubmed/29159011 http://dx.doi.org/10.7759/cureus.1705

Ejemplares similares

New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma
por: Rossini, Marika, et al.
Publicado: (2018)

Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020)

Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future
por: Nicolini, Fabio, et al.
Publicado: (2020)

Dosimetric Advantages of Silicone-Filled Vaginal Spacers in Pediatric Proton Therapy
por: Ates, Ozgur, et al.
Publicado: (2022)

Evaluation of the dosimetric effect of scattered protons in clinical practice in passive scattering proton therapy
por: Kim, Chankyu, et al.
Publicado: (2021)

Evaluation of dosimetric advantages of using patient‐specific aperture system with intensity‐modulated proton therapy for the shallow depth tumor
por: Yasui, Keisuke, et al.
Publicado: (2017)

Dosimetric advantages of proton beam therapy compared to intensity-modulated radiation therapy for retroperitoneal chordoma
por: Yu, Nathan Y, et al.
Publicado: (2019)

Dosimetric impact of range uncertainty in passive scattering proton therapy
por: Liu, Ruirui, et al.
Publicado: (2021)

Immune Microenvironment and Genetics in Malignant Pleural Mesothelioma
por: Wadowski, Benjamin, et al.
Publicado: (2021)

Collimating individual beamlets in pencil beam scanning proton therapy, a dosimetric investigation
por: Holmes, Jason, et al.
Publicado: (2022)

Current State of Pleural-Directed Adjuncts Against Malignant Pleural Mesothelioma
por: Choi, Agnes Y., et al.
Publicado: (2022)

Clinical experience of volumetric modulated arc therapy for malignant pleural mesothelioma after extrapleural pneumonectomy
por: Kimura, Tomoki, et al.
Publicado: (2015)

Stereotactic body proton therapy for liver tumors: Dosimetric advantages and their radiobiological and clinical implications
por: Arscott, W. Tristram, et al.
Publicado: (2018)

A pilot study of volumetric‐modulated arc therapy for malignant pleural mesothelioma
por: Runxiao, Li, et al.
Publicado: (2016)

Secondary Malignancy Risk Following Proton Radiation Therapy
por: Eaton, Bree R., et al.
Publicado: (2015)

Dosimetric Comparison of Lung-Sparing Radiation Therapy between Volumetric Arc Therapy and Helical Tomotherapy for Unresectable Malignant Pleural Mesothelioma
por: Pehlivan, Berrin, et al.
Publicado: (2019)

Development and Validation of a Prognostic Signature for Malignant Pleural Mesothelioma
por: Zhou, Jian-Guo, et al.
Publicado: (2019)

Emerging Treatments for Malignant Pleural Mesothelioma: Where Are We Heading?
por: Cantini, Luca, et al.
Publicado: (2020)

Editorial: Emerging Therapies for Malignant Mesothelioma
por: van Zandwijk, Nico, et al.
Publicado: (2020)

Pro-con of proton: Dosimetric advantages of intensity-modulation over passive scatter for thoracic malignancies
por: Jie, Ang Wei, et al.
Publicado: (2020)

Association of RERG Expression with Female Survival Advantage in Malignant Pleural Mesothelioma
por: De Rienzo, Assunta, et al.
Publicado: (2021)

Liquid Biopsy in Malignant Pleural Mesothelioma: State of the Art, Pitfalls, and Perspectives
por: Cavallari, Ilaria, et al.
Publicado: (2019)

Cellular Immunotherapy and Locoregional Administration of CAR T-Cells in Malignant Pleural Mesothelioma
por: Belderbos, Robert A., et al.
Publicado: (2020)

Malignant Pleural Mesothelioma Epidemiology in the United States From 2000 to 2016
por: Thomas, Akesh, et al.
Publicado: (2021)

Editorial: Advances in malignant pleural mesothelioma: Diagnosis, treatment, and molecular mechanisms
por: Mastromarino, Maria Giovanna, et al.
Publicado: (2023)

First-ever Abscopal Effect after Palliative Radiotherapy and Immuno-gene Therapy for Malignant Pleural Mesothelioma
por: Barsky, Andrew R, et al.
Publicado: (2019)

Stereotactic Body Radiation Therapy (SBRT) as Salvage Therapy for Oligorecurrent Pleural Mesothelioma After Multi-Modality Therapy
por: Schröder, Christina, et al.
Publicado: (2019)

Compensator‐based intensity‐modulated radiation therapy for malignant pleural mesothelioma post extrapleural pneumonectomy
por: Javedan, Khosrow, et al.
Publicado: (2008)

Target Therapy in Malignant Pleural Mesothelioma: Hope or Mirage?
por: Borea, Federica, et al.
Publicado: (2023)

Trimodality therapy of malignant pleural mesothelioma with helical tomotherapy
por: Ozyurt, Hazan, et al.
Publicado: (2023)

MicroRNAs for the Diagnosis and Management of Malignant Pleural Mesothelioma: A Literature Review
por: Lo Russo, Giuseppe, et al.
Publicado: (2018)

Therapeutic Landscape of Malignant Pleural Mesothelioma: Collateral Vulnerabilities and Evolutionary Dependencies in the Spotlight
por: Xu, Duo, et al.
Publicado: (2020)

Tumor Microenvironment-Associated Immune-Related Genes for the Prognosis of Malignant Pleural Mesothelioma
por: Xu, Xiaoling, et al.
Publicado: (2020)

Manipulating microRNAs for the Treatment of Malignant Pleural Mesothelioma: Past, Present and Future
por: Reid, Glen, et al.
Publicado: (2020)

Circulating Epigenetic Biomarkers in Malignant Pleural Mesothelioma: State of the Art and critical Evaluation
por: Ferrari, Luca, et al.
Publicado: (2020)

Complete Pathological Response After Neoadjuvant Chemo-Immunotherapy in Malignant Pleural Mesothelioma
por: Tostes, Francinne T., et al.
Publicado: (2022)

Dosimetric evaluation of helical tomotherapy and volumetric-modulated arc therapy for malignant pleural mesothelioma: a planning study for dose escalation
por: Zhang, Fu-Li, et al.
Publicado: (2021)

Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma
por: Harrabi, S. B., et al.
Publicado: (2016)

Trend analysis of the dosimetric impact of anatomical changes during proton therapy for maxillary sinus carcinoma
por: Narita, Yuki, et al.
Publicado: (2021)

Heart and Cardiac Substructure Dose Sparing in Synchronous Bilateral Breast Radiotherapy: A Dosimetric Study of Proton and Photon Radiation Therapy
por: Sun, Tao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u0c4fn1jsm0uadr8d19dk3nduk